Brain-penetrating nanoparticles for analysis of the brain microenvironment

Methods in Molecular Biology

Volumn 1570, Issue , 2017, Pages 91-104

  Nance, Elizabeth ^a  

^a University of Washington   (United States)

Author keywords

Brain penetrating nanoparticle; Carboxyl amine reaction; PEG density; PEGylation; Polystyrene

Indexed keywords

BRAIN PENETRATING NANOPARTICLE; DNA; MACROGOL; NANOPARTICLE; POLYSTYRENE; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE; POLYSTYRENE DERIVATIVE;

BLOOD BRAIN BARRIER; BRAIN; BRAIN MICROENVIRONMENT; CONJUGATION; DENSITY; DISPERSITY; DRUG DELIVERY SYSTEM; HUMAN; HYDRODYNAMICS; MOLECULAR WEIGHT; NANOMEDICINE; PERMEABILITY; POLYMERIZATION; SURFACE AREA; SURFACE CHARGE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; METABOLISM; MOUSE; PARTICLE SIZE; TUMOR MICROENVIRONMENT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELLULAR MICROENVIRONMENT; DRUG DELIVERY SYSTEMS; MICE; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYSTYRENES;

EID: 85014007719     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6840-4_6     Document Type: Chapter

References (24)

1. Patel T, Zhou J, Piepmeier JM, Saltzman WM (2012) Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 64(7):701–705. doi:10.1016/j.addr.2011.12.006
2. Nance EA, Woodworth GF, Sailor KA, Shih TY, Xu Q, Swaminathan G, Xiang D, Eberhart C, Hanes J (2012) A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med 4(149):149ra119. doi:10.1126/scitranslmed.3003594
3. Nance E, Timbie K, Miller GW, Song J, Louttit C, Klibanov AL, Shih TY, Swaminathan G, Tamargo RJ, Woodworth GF, Hanes J, Price RJ (2014) Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound. J Control Release 189:123–132. doi:10.1016/j.jconrel.2014.06.031
4. Strohbehn G, Coman D, Han L, Ragheb RR, Fahmy TM, Huttner AJ, Hyder F, Piepmeier JM, Saltzman WM, Zhou J (2015) Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance. J Neurooncol 121(3):441–449. doi:10.1007/s11060-014-1658-0
5. Nance E, Zhang C, Shih TY, Xu Q, Schuster BS, Hanes J (2014) Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano 8(10):10655–10664. doi:10.1021/nn504210g
6. Mead BP, Mastorakos P, Suk JS, Klibanov AL, Hanes J, Price RJ (2016) Targeted gene transfer to the brain via the delivery of brainpenetrating DNA nanoparticles with focused ultrasound. J Control Release 223:109–117. doi:10.1016/j.jconrel.2015.12.034
7. Burke CW, Suk JS, Kim AJ, Hsiang YH, Klibanov AL, Hanes J, Price RJ (2012) Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of nonviral gene nanocarriers with microbubbles. J Control Release 162(2):414–421. doi:10.1016/j.jconrel.2012.07.005
8. Wohlfart S, Gelperina S, Kreuter J (2012) Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release 161(2): 264–273. doi:10.1016/j.jconrel.2011.08.017
9. Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2–14. doi:10.1016/j.addr.2013.08.008
10. Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, Duong N, Schafbauer T, Huttner AJ, Huang Y, Carson RE, Zhang Y, Sullivan DJ Jr, Piepmeier JM, Saltzman WM (2013) Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci USA 110(29):11751–11756. doi:10.1073/pnas.1304504110
11. Yang M, Lai SK, Wang YY, Zhong W, Happe C, Zhang M, Fu J, Hanes J (2011) Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem Int Ed Engl 50(11):2597–2600. doi:10.1002/anie.201006849
12. Tang BC, Dawson M, Lai SK, Wang YY, Suk JS, Yang M, Zeitlin P, Boyle MP, Fu J, Hanes J (2009) Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proc Natl Acad Sci USA 106 (46):19268–19273. doi:10.1073/pnas.0905998106
13. Nance E, Porambo M, Zhang F, Mishra MK, Buelow M, Getzenberg R, Johnston M, Kannan RM, Fatemi A, Kannan S (2015) Systemic dendrimer-drug treatment of ischemiainduced neonatal white matter injury. J Control Release 214:112–120. doi:10.1016/j.jconrel.2015.07.009
14. Kannan S, Dai H, Navath RS, Balakrishnan B, Jyoti A, Janisse J, Romero R, Kannan RM (2012) Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med 4(130):130ra146. doi:10.1126/scitranslmed.3003162
15. Jenkins SI, Weinberg D, Al-Shakli AF, Fernandes AR, Yiu HH, Telling ND, Roach P, Chari DM (2016) ‘Stealth’ nanoparticles evade neural immune cells but also evade major brain cell populations: implications for PEG-based neurotherapeutics. J Control Release 224:136–145. doi:10.1016/j.jconrel.2016.01.013
16. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM (2015) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery, Adv Drug Deliv Rev. doi:10.1016/j.addr.2015.09.012
17. Popielarski SR, Pun SH, Davis ME (2005) A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization. Bioconjug Chem 16(5):1063–1070. doi:10.1021/bc050113d
18. Wang YY, Lai SK, Suk JS, Pace A, Cone R, Hanes J (2008) Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier. Angew Chem Int Ed Engl 47(50): 9726–9729. doi:10.1002/anie.200803526
19. Perry JL, Reuter KG, Kai MP, Herlihy KP, Jones SW, Luft JC, Napier M, Bear JE, DeSimone JM (2012) PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 12 (10):5304–5310. doi:10.1021/nl302638g
20. Pombo Garcia K, Zarschler K, Barbaro L, Barreto JA, O’Malley W, Spiccia L, Stephan H, Graham B (2014) Zwitterionic-coated “stealth” nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. Small 10 (13):2516–2529. doi:10.1002/smll.201303540
21. Amoozgar Z, Yeo Y (2012) Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4(2):219–233. doi:10.1002/wnan.1157
22. Yang Q, Lai SK (2015) Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7(5):655–677. doi:10.1002/wnan.1339
23. Rizzo V, Pinciroli V (2005) Quantitative NMR in synthetic and combinatorial chemistry. J Pharm Biomed Anal 38(5):851–857. doi:10.1016/j.jpba.2005.01.045
24. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM (2016) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99(Pt A):28–51. doi:10.1016/j.addr.2015.09.012